TRML
Price:
$47.98
Market Cap:
$1.23B
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Industry
Biotechnology
IPO Date
2021-05-07
Stock Exchange
NASDAQ
Ticker
TRML
According to Tourmaline Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.20B. This represents a change of 158.80% compared to the average of 464.20M of the last 4 quarters.
The mean historical Enterprise Value of Tourmaline Bio, Inc. over the last ten years is 505.95M. The current 1.20B Enterprise Value has changed 23.64% with respect to the historical average. Over the past ten years (40 quarters), TRML's Enterprise Value was at its highest in in the March 2022 quarter at 1.05B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
505.95M
Median
341.74M
Minimum
-16034540.00
Maximum
1.64B
Discovering the peaks and valleys of Tourmaline Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.71%
Maximum Annual Enterprise Value = 1.64B
Minimum Annual Increase = -3117.21%
Minimum Annual Enterprise Value = -16034540.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 483.80M | -3117.21% |
| 2023 | -16034540.00 | -108.03% |
| 2022 | 199.68M | -87.86% |
| 2021 | 1.64B | 1.71% |
| 2020 | 91.04M | -85.61% |
The current Enterprise Value of Tourmaline Bio, Inc. (TRML) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
222.48M
5-year avg
480.56M
10-year avg
505.95M
Tourmaline Bio, Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (2.30B), less than Precigen, Inc. (1.22B), greater than Immatics N.V. (919.37M), greater than ORIC Pharmaceuticals, Inc. (1.06B), greater than Enliven Therapeutics, Inc. (1.15B), greater than Amylyx Pharmaceuticals, Inc. (985.24M), less than Relay Therapeutics, Inc. (1.33B), less than Dianthus Therapeutics, Inc. (1.56B), greater than Wave Life Sciences Ltd. (1.07B), less than Syndax Pharmaceuticals, Inc. (1.94B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.30B | $2.44B | |
| 1.22B | $1.13B | |
| 919.37M | $1.44B | |
| 1.06B | $1.11B | |
| 1.15B | $1.27B | |
| 985.24M | $1.20B | |
| 1.33B | $1.39B | |
| 1.56B | $1.62B | |
| 1.07B | $1.25B | |
| 1.94B | $1.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tourmaline Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tourmaline Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tourmaline Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tourmaline Bio, Inc. (TRML)?
What is the 3-year average Enterprise Value for Tourmaline Bio, Inc. (TRML)?
What is the 5-year average Enterprise Value for Tourmaline Bio, Inc. (TRML)?
How does the current Enterprise Value for Tourmaline Bio, Inc. (TRML) compare to its historical average?